Acupuncture for emotional disorders in patients with inflammatory bowel disease: a systematic review protocol.

Inflammatory bowel disease (IBD), which includes conditions like Crohn's disease and ulcerative colitis, often comes with emotional challenges such as anxiety and depression. These emotional difficulties can significantly reduce quality of life for people living with IBD. Researchers are planning a comprehensive review to examine whether acupuncture can help manage these emotional symptoms in IBD patients.

This study is a systematic review protocol, meaning it outlines a plan for researchers to collect and analyze all existing research on acupuncture for emotional disorders in IBD patients. The research team will search nine major medical databases for clinical trials published through October 2021, including studies in both English and Chinese. They're specifically looking for randomized controlled trials—the gold standard in medical research—that tested acupuncture therapy for IBD patients experiencing emotional difficulties.

The main focus will be on measuring improvements in emotional functioning, such as reductions in anxiety or depression symptoms. The researchers will also look at IBD disease activity markers, inflammation levels, and any side effects reported from acupuncture treatment. This comprehensive approach will help determine not just whether acupuncture works for emotional symptoms, but also whether it affects the underlying bowel condition.

It's important to note that this is a protocol paper, meaning the actual review hasn't been completed yet. The findings, once published, could provide valuable evidence about whether acupuncture is an effective complementary treatment option for IBD patients struggling with emotional health. If you're considering acupuncture for IBD-related emotional symptoms, consult with a licensed acupuncturist experienced in treating digestive and emotional conditions.

This systematic review protocol outlines a comprehensive methodology to evaluate acupuncture's effectiveness for emotional disorders in inflammatory bowel disease (IBD) patients. The planned review will search nine databases including MEDLINE, EMBASE, Cochrane CENTRAL, and major Chinese medical databases from inception through October 2021, with no language restrictions. Only randomized controlled trials examining acupuncture therapy for IBD patients with comorbid emotional disorders will be included.

Primary outcomes focus on emotional functioning measures, while secondary outcomes include Colitis Activity Index, Crohn's Disease Activity Index, C-reactive protein levels, and adverse events. Multiple assessors will perform study selection, data extraction, and bias assessment. Data synthesis will employ random-effects modeling using RevMan 5.4, with dichotomous data presented as risk ratios and continuous data as weighted or standardized mean differences.

Clinical significance: This protocol represents a rigorous approach to evaluating acupuncture's dual therapeutic potential for both emotional and inflammatory components of IBD. The inclusion of Chinese databases may capture studies not typically represented in Western reviews, potentially expanding the evidence base for this integrated treatment approach.